跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,208 条关于
“Corbus Pharmaceuticals Holdings”
全部
10,208
临床试验
972
药物
1,798
机构
2,206
资讯
5,232
去年
Corbus Pharmaceuticals Doses First Patient in Phase 1 Trial of CRB-601 for Advanced Solid Tumors
9个月前
Corbus and Eli Lilly Report Positive Obesity Drug Trial Results, Driving Stock Gains
去年
Corbus Pharmaceuticals Presents Promising Phase 1 Data for Nectin-4 ADC CRB-701 at ASCO GU
9个月前
Corbus Pharmaceuticals' CRB-913 Shows Promising Weight Loss Results in Phase 1a Obesity Trial
前天
Corbus' Oral CB1 Inverse Agonist CRB-913 Delivers 5% Weight Loss at 12 Weeks in Phase 1b CANYON-1 Trial
去年
FDA Cancels Advisory Committee Meeting for Applied Therapeutics' Govorestat, Boosting Approval Prospects
去年
Corbus Pharmaceuticals Receives FDA Fast Track Designation for Investigational Therapy
去年
FDA Grants Fast Track Designation to CRB-701 ADC for Recurrent Head and Neck Cancer
去年
Corbus Pharmaceuticals Initiates Phase 1 Trial of Peripherally Restricted CB1 Inverse Agonist for Obesity
去年
CB1 Agonist Trial Results Trigger Stock Drop for Corbus and Novo Nordisk
第 1 页，共 524 页
上一页
下一页
